ORTHOPEDIATRICS CORP Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Orthopediatrics Corp quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2022 to Q1 2024.
  • Orthopediatrics Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$2.45M, a 326% decline year-over-year.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$2.45M -$1.87M -326% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 -$574K -$257K -81.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 -$317K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.